iNtODEWORLD | iNtRON Biotechnology, Inc. attended the 38th Annual J.P. Morgan Healthcare Conference
21343
single,single-post,postid-21343,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,qode-theme-ver-11.0,qode-theme-bridge,wpb-js-composer js-comp-ver-5.1.1,vc_responsive

iNtRON Biotechnology, Inc. attended the 38th Annual J.P. Morgan Healthcare Conference

iNtRON Biotechnology attended the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14, 2020. J.P. Morgan’s Healthcare Conference is Wall Street’s premier investor conference aimed exclusively towards companies defining the healthcare industry. J.P. Morgan Healthcare Conference continues their tradition of hosting the largest and most informative healthcare investment symposium in the industry. This year, they are expected to host more than 400 companies, both public and private, to deliver presentations to over 9,000 attendees.

iNtRON Bio is a biotechnology company whose mission is to search, collect, and develop bacteriophages for unmet therapeutic needs by preserving and promoting gut microbiota. iNtRON aims to become a ‘global R&D company’ and game-changers in the innovation of antibacterial drugs against superbugs and persister cells.

 

it is iNtRON.

if it is iNtRON?



iNtODEWORLD, Inc is the US subsidiary of iNtRON Biotechnology, Inc.
PGlmcmFtZSB3aWR0aD0iNzAwIiBoZWlnaHQ9IjM5NCIgc3JjPSJodHRwczovL3d3dy55b3V0dWJlLmNvbS9lbWJlZC81UDMxdTh6emF6az9yZWw9MCIgZnJhbWVib3JkZXI9IjAiIGFsbG93PSJhdXRvcGxheTsgZW5jcnlwdGVkLW1lZGlhIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+